DIRECTOR DEALINGS: Oxford Biomedica Directors Buy Open-Offer Shares
LONDON (Alliance News) - Biopharmaceutical company Oxford Biomedica PLC Monday said a group of directors including Chairman Nick Rodgers purchased a total of 136.2 million shares among them as part of the biopharmaceutical company's recent fund raising. Non-Executive Director Marti Read More